Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Cannabis Bioscience International Holdings (CBIH) over the last 5 years, with Q2 2025 value amounting to $150000.0.

  • Cannabis Bioscience International Holdings' Share-based Compensation rose 29476.8% to $150000.0 in Q2 2025 from the same period last year, while for Aug 2025 it was $287997.0, marking a year-over-year increase of 21805.43%. This contributed to the annual value of $220000.0 for FY2025, which is 9469.54% up from last year.
  • As of Q2 2025, Cannabis Bioscience International Holdings' Share-based Compensation stood at $150000.0, which was up 29476.8% from $100000.0 recorded in Q3 2024.
  • Over the past 5 years, Cannabis Bioscience International Holdings' Share-based Compensation peaked at $150000.0 during Q2 2025, and registered a low of -$493859.0 during Q2 2023.
  • For the 3-year period, Cannabis Bioscience International Holdings' Share-based Compensation averaged around -$51465.5, with its median value being $68998.5 (2024).
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 10769.39% in 2024, then soared by 29476.8% in 2025.
  • Cannabis Bioscience International Holdings' Share-based Compensation (Quarter) stood at -$493859.0 in 2023, then surged by 120.25% to $100000.0 in 2024, then skyrocketed by 50.0% to $150000.0 in 2025.
  • Its Share-based Compensation stands at $150000.0 for Q2 2025, versus $100000.0 for Q3 2024 and $37997.0 for Q2 2024.